Journal of Cancer Clinical Trials

ISSN: 2577-0535

Open Access

Chemo-resistant Leukemia Cells


Thomas Kalhor

Leukemia, positioning the primary spot in youthful individuals' harmful infections, is the dangerous tumor of hematopoietic framework. As of now, chemotherapy is still a significant treatment strategy for leukemia. However with the utilization of chemotherapy drugs, leukemia cells step by step create opposition coming about in chemotherapy disappointment. The acquired (regular) or procured drug opposition, particularly multidrug opposition (MDR) is viewed as the significant reason for chemotherapy disappointment. In spite of unmistakable components, MDR is generally the helpful impact of a mix of MDR systems like obstructing apoptosis and expanding drug efflux. Among drug efflux carriers, the most broadly examined is adenosine triphosphate-restricting tape (ABC) carriers


Share this article

Google scholar citation report
Citations: 103

Journal of Cancer Clinical Trials received 103 citations as per google scholar report

Journal of Cancer Clinical Trials peer review process verified at publons

Indexed In

arrow_upward arrow_upward